Novartis

Results: 1795



#Item
31Ausschreibung NOVARTIS-PREIS FÜR THERAPIERELEVANTE PHARMAKOLOGISCHE FORSCHUNG Pharmakologische Grundlagenforschung und klinische Anwendung von Arzneimitteln gehören eng zusammen, wenn die jeweiligen Forschungsaktivitä

Ausschreibung NOVARTIS-PREIS FÜR THERAPIERELEVANTE PHARMAKOLOGISCHE FORSCHUNG Pharmakologische Grundlagenforschung und klinische Anwendung von Arzneimitteln gehören eng zusammen, wenn die jeweiligen Forschungsaktivitä

Add to Reading List

Source URL: www.dgpt-online.de

- Date: 2016-05-04 17:42:15
    32PRESSEINFORMATION Novartis Vaccines and Diagnostics ist 7.000stes GPM Mitglied Nürnberg, 3. Juli 2015 – Zuwachs für Deutschlands größtes Netzwerk für Projektmanager: Novartis Vaccines and Diagnostics GmbH ist das

    PRESSEINFORMATION Novartis Vaccines and Diagnostics ist 7.000stes GPM Mitglied Nürnberg, 3. Juli 2015 – Zuwachs für Deutschlands größtes Netzwerk für Projektmanager: Novartis Vaccines and Diagnostics GmbH ist das

    Add to Reading List

    Source URL: www.gpm-ipma.de

    - Date: 2015-07-03 06:03:06
      33ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for

      ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for

      Add to Reading List

      Source URL: www.abirisk.eu

      Language: English - Date: 2012-06-04 10:07:55
      34January 8, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

      January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

      Add to Reading List

      Source URL: www.dcat.org

      Language: English - Date: 2016-01-11 11:16:23
      35IEBA International Employee Benefits Association IEBA–CH MEETING

      IEBA International Employee Benefits Association IEBA–CH MEETING

      Add to Reading List

      Source URL: www.ieba.org.uk

      Language: English - Date: 2016-06-06 05:23:51
      36alternative to diovan what is generic for diovan. maker of diovan. buy diovan 320 mg, picture of 80 mg diovan pill, diovan generic alternatives diovan being pulled off the market diovan complaints footpain diovan, buying

      alternative to diovan what is generic for diovan. maker of diovan. buy diovan 320 mg, picture of 80 mg diovan pill, diovan generic alternatives diovan being pulled off the market diovan complaints footpain diovan, buying

      Add to Reading List

      Source URL: pulseseismic.com

      Language: English - Date: 2016-08-23 22:37:06
      37Microsoft Word - Novartis und der UNGC Forum-Wirtschaftsethik.docx

      Microsoft Word - Novartis und der UNGC Forum-Wirtschaftsethik.docx

      Add to Reading List

      Source URL: www.globalewerteallianz.ch

      Language: German - Date: 2014-07-30 13:36:11
        38EFPIA Annual Report 2015  @EFPIA Introduction

        EFPIA Annual Report 2015 @EFPIA Introduction

        Add to Reading List

        Source URL: www.efpia.eu

        Language: English - Date: 2016-06-15 04:09:40
        39February 5, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum.  Sponsored By:

        February 5, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum.  Sponsored By:

        Add to Reading List

        Source URL: www.dcat.org

        Language: English - Date: 2016-02-09 09:31:44
        40Corporate Social Responsibility From the Novartis perspective Dr. Joerg Reinhardt Chairman Bern, June

        Corporate Social Responsibility From the Novartis perspective Dr. Joerg Reinhardt Chairman Bern, June

        Add to Reading List

        Source URL: www.swissholdings.ch

        Language: English - Date: 2016-06-10 02:39:23